Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01499394 · ClinicalTrials.gov registry record
Caris Biorepository Research Protocol
A clinical trial of Cancer and Minimal Residual Disease, sponsored by Caris Science.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 20
- Study locations
NCT01499394: Recruiting study of Cancer and Minimal Residual Disease, sponsored by Caris Science.
NCT01499394 is a study of Cancer and Minimal Residual Disease that is actively recruiting participants, run by Caris Science. The registered enrollment target is 100,000 participants, above the 3,329-participant average among 615 other Cancer trials with a reported enrollment target (2904% higher). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01499394, a study of Cancer and Minimal Residual Disease, is actively recruiting participants, sponsored by Caris Science.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.
Primary Outcome
Retention of biospecimen samples with DNA
Conditions Studied
Study Locations (20)
Florida
- Lee Memorial Health System - Fort Myers
- Cancer Care of North Florida - Lake City
- Advent Health - Orlando
- The University of South Florida - Tampa
- Cleveland Clinic Florida - Weston
Georgia
- Phoebe Putney Memorial Hospital - Albany
- Emory University - Atlanta
- Augusta University Research Institute - Augusta
- Cancer Center of Middle Georgia - Dublin
Arkansas
- St. Bernards Medical Center - Jonesboro
- CARTI Cancer Center - Little Rock
- ObjectiveHealth - ARcare Center for Clinical Research - Little Rock
Louisiana
- CHRISTUS - St. Frances Cabrini Hospital - Alexandria
- Tulane University - New Orleans
- CHRISTUS - Highland Medical Center - Shreveport
Maryland
- Mercy Medical Center - Baltimore
- Sinai Hospital of Baltimore - Baltimore
Alabama
- University of South Alabama - Mobile
Arizona
- Southwest Medical Imaging - Scottsdale
Illinois
- Hope and Healing Cancer Services - Hinsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2010-11 |
| Est. Completion | 2035-11 |
What NCT01499394 shows while recruiting
NCT01499394 is an observational study that tracks outcomes without assigning an intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,329-participant average among 615 other Cancer trials with a reported enrollment target (2904% higher).
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01499394 names 20 study sites across 8 states, led by Florida, Georgia, Arkansas.
Frequently Asked Questions
What is clinical trial NCT01499394 about?
NCT01499394 is a clinical study titled "Caris Biorepository Research Protocol". The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collecte...
What is the current status of trial NCT01499394?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2010-11. Estimated completion is 2035-11.
What conditions does trial NCT01499394 study?
This clinical trial studies the following conditions: Cancer, Minimal Residual Disease, Early Detection of Cancer.
Who is sponsoring clinical trial NCT01499394?
This trial is sponsored by Caris Science, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01499394 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01499394's enrollment target sits among peer trials
100,000 5th of 615 higher than 609 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia